Abstract

Inclisiran (Leqvio) is a double‐stranded, siRNA cholesterol‐lowering agent for the treatment of primary hypercholesterolaemia or mixed dyslipidaemia. This article discusses its mode of action, efficacy and place in therapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call